SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%

Millendo Therapeutics Q1 EPS $(0.650) Up From $(0.780) YoY

Millendo Therapeutics (NASDAQ:MLND) reported quarterly losses of $(0.650) per share. This is a 16.67 percent increase over losses of $(0.780) per share from the same period last year.

Benzinga · 05/08/2020 12:33

Millendo Therapeutics (NASDAQ:MLND) reported quarterly losses of $(0.650) per share. This is a 16.67 percent increase over losses of $(0.780) per share from the same period last year.